Table 2.

Univariable analysis of factors associated with willingness to repeat the liver biopsy.

Determinant	Odds Ratio (95% CI)
Age (≤45 yrs vs. > 45 yrs)	2.20 (0.50 – 9.80)
Female sex	0.44 (0.19 – 1.02)
African-American race	0.96 (0.42 – 2.19)
HIV-coinfected	1.42 (0.67 – 3.03)
Prior history of injection drug use	1.48 (0.69 – 3.15)
History of psychiatric disease	1.11 (0.52 – 2.36)
At least high school graduate	1.99 (0.90 – 4.38)
Employed	0.75 (0.32 – 1.73)
Blind percutaneous vs. other method	0.75 (0.32 – 1.73)
Time since prior biopsy (<=1 year vs. >1 year)	1.13 (0.51 – 2.53)
Minimal fibrosis (METAVIR ≤F1or Ishak ≤F2)	1.03 (0.49 – 2.19)
Previously treated for chronic HCV infection	1.12 (0.53 – 2.35)
Interview questions:
Considers the biopsy safe	4.45 (1.50 – 13.27)
Considers the biopsy important	4.87 (1.83 – 12.95)
Knows a friend who has had a biopsy	3.45 (1.16 – 10.23)

HIV=human immunodeficiency virus; HCV=hepatitis C virus infection